Cost-effectiveness analysis of first-line combination chemotherapy regimens for metastatic pancreatic cancer and evidence-based pricing strategy of liposomal irinotecan in China

ABSTRACT:

SUBMITTER: Xiang Z 

PROVIDER: S-EPMC11695189 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature